Back to 
Belvedere Trading LLC
Belvedere Trading LLC
PTGX
Showing 0 of 5 quarters
Position history for Belvedere Trading LLC's holdings in PROTAGONIST THERAPEUTICS INC
No. Belvedere Trading exited its PTGX (Protagonist Therapeutics) position in Q2 2023. Its Q1 2023 13F listed 24,011 shares worth $552,253. Belvedere Trading first reported PTGX in Q3 2021 and held it in 3 quarterly 13F filings.
Current Value
—
Current Shares
—
Total Value Change
$0
Total Shares Change
0
No position history available for this security.